183 related articles for article (PubMed ID: 19904270)
21. Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of non‑small cell lung cancer cells in vitro and in vivo.
Zhang H; Li Z; Wang K; Ren P
Oncol Rep; 2015 Mar; 33(3):1079-88. PubMed ID: 25524805
[TBL] [Abstract][Full Text] [Related]
22. Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.
Douillard JY; Gervais R; Dabouis G; Le Groumellec A; D'Arlhac M; Spaeth D; Coudert B; Caillaud D; Monnier A; Clary C; Maury B; Mornet M; Rivière A; Clouet P; Couteau C
Ann Oncol; 2005 Jan; 16(1):81-9. PubMed ID: 15598943
[TBL] [Abstract][Full Text] [Related]
23. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC
Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
Holt SV; Brookes KE; Dive C; Makin GW
Oncol Rep; 2011 Apr; 25(4):1177-81. PubMed ID: 21286665
[TBL] [Abstract][Full Text] [Related]
25. Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
Cillessen SA; Reed JC; Welsh K; Pinilla C; Houghten R; Hooijberg E; Deurhof J; Castricum KC; Kortman P; Hess CJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Blood; 2008 Jan; 111(1):369-75. PubMed ID: 17916749
[TBL] [Abstract][Full Text] [Related]
26. A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.
Lang DS; Droemann D; Schultz H; Branscheid D; Martin C; Ressmeyer AR; Zabel P; Vollmer E; Goldmann T
Respir Res; 2007 Jun; 8(1):43. PubMed ID: 17567922
[TBL] [Abstract][Full Text] [Related]
27. Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell cultures.
Ricotti L; Barzanti F; Tesei A; Amadori D; Gasperi-Campani A; Frassineti GL; Zoli W
Ann Oncol; 2000 May; 11(5):587-94. PubMed ID: 10907953
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D
Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899
[TBL] [Abstract][Full Text] [Related]
29. Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer.
Kenmotsu H; Ohde Y; Wakuda K; Nakashima K; Omori S; Ono A; Naito T; Murakami H; Kojima H; Takahashi S; Isaka M; Endo M; Takahashi T
Cancer Chemother Pharmacol; 2017 Sep; 80(3):609-614. PubMed ID: 28761967
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
Hillner BE; Smith TJ
Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
[TBL] [Abstract][Full Text] [Related]
31. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
[TBL] [Abstract][Full Text] [Related]
32. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
[TBL] [Abstract][Full Text] [Related]
33. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S
Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345
[TBL] [Abstract][Full Text] [Related]
34. Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
Le Chevalier T; Brisgand D; Soria JC; Douillard JY; Pujol JL; Ruffie P; Aberola V; Cigolari S
Oncologist; 2001; 6 Suppl 1():8-11. PubMed ID: 11181998
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Wozniak AJ; Crowley JJ; Balcerzak SP; Weiss GR; Spiridonidis CH; Baker LH; Albain KS; Kelly K; Taylor SA; Gandara DR; Livingston RB
J Clin Oncol; 1998 Jul; 16(7):2459-65. PubMed ID: 9667264
[TBL] [Abstract][Full Text] [Related]
36. Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.
Pérol M; Léna H; Thomas P; Robinet G; Fournel P; Coste E; Belleguic C; Le Caer H; Blanchon F; Vergnenègre A; Vernejoux JM; Schuller-Lebeau MP; Pham E
Ann Oncol; 2002 May; 13(5):742-7. PubMed ID: 12075743
[TBL] [Abstract][Full Text] [Related]
37. Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group.
Furuse K; Fukuoka M; Kuba M; Yamori S; Nakai Y; Negoro S; Katagami N; Takada Y; Kinuwaki E; Kawahara M; Kubota K; Sakuma A; Niitani H
Ann Oncol; 1996 Oct; 7(8):815-20. PubMed ID: 8922195
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer.
Kobayashi M; Matsui K; Hirashima T; Nitta T; Sasada S; Tada T; Minakuchi K; Furukawa M; Ogata Y; Kawase I
Int J Clin Oncol; 2006 Aug; 11(4):314-9. PubMed ID: 16937306
[TBL] [Abstract][Full Text] [Related]
39. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B
Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677
[TBL] [Abstract][Full Text] [Related]
40. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
Pérol M; Guérin JC; Thomas P; Poirier R; Carles P; Robinet G; Kleisbauer JP; Paillotin D; Vergnenègre A; Balmes P; Touron D; Grivaux M; Pham E
Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
